A Goldhirsch Selected Research

A Goldhirsch Research Topics

Disease

114	Breast Neoplasms (Breast Cancer) 01/2023 - 01/2000
51	Neoplasms (Cancer) 10/2022 - 02/2000
11	Neoplasm Metastasis (Metastasis) 10/2013 - 12/2000
3	Disease Progression 01/2017 - 02/2001
3	Carcinoma (Carcinomatosis) 04/2016 - 03/2000
3	Stomach Neoplasms (Stomach Cancer) 04/2016 - 03/2000
3	Lymphoma (Lymphomas) 02/2007 - 06/2001
2	Noninfiltrating Intraductal Carcinoma (DCIS) 04/2015 - 12/2003
2	Residual Neoplasm 02/2015 - 09/2005
2	Triple Negative Breast Neoplasms 02/2012 - 01/2011
2	Osteonecrosis (Kienbock's Disease) 01/2008 - 10/2006
2	Adenocarcinoma 07/2004 - 01/2001
2	Venous Thrombosis (Deep-Vein Thrombosis) 04/2004 - 01/2001
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2001 - 07/2000
2	Cardiotoxicity 08/2000 - 06/2000
2	Febrile Neutropenia 08/2000 - 03/2000
1	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 10/2022
1	Amenorrhea 09/2017
1	Primary Ovarian Insufficiency 08/2015
1	Arthralgia (Joint Pain) 01/2014
1	Myalgia 01/2014
1	Fatigue 05/2012
1	Hypersensitivity (Allergy) 03/2012
1	Testicular Neoplasms (Testicular Cancer) 01/2011
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 12/2009
1	Osteoporosis 09/2009
1	Bone Fractures (Bone Fracture) 09/2009
1	Melanoma (Melanoma, Malignant) 01/2009

Drug/Important Bio-Agent (IBA)

20	Tamoxifen FDA LinkGeneric 12/2015 - 04/2000
18	Fluorouracil (Carac)FDA LinkGeneric 04/2016 - 01/2000
18	Estrogen ReceptorsIBA 03/2013 - 02/2000
13	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2012 - 04/2000
13	Vinorelbine (Navelbine)FDA LinkGeneric 09/2009 - 01/2000
12	Hormones (Hormone)IBA 01/2023 - 08/2000
12	Progesterone Receptors (Progesterone Receptor)IBA 03/2013 - 08/2000
11	AnthracyclinesIBA 08/2015 - 08/2000
11	Methotrexate (Mexate)FDA LinkGeneric 02/2012 - 04/2000
10	Cisplatin (Platino)FDA LinkGeneric 04/2016 - 01/2000
9	Letrozole (Femara)FDA LinkGeneric 10/2021 - 09/2006
8	human ERBB2 proteinIBA 04/2015 - 12/2007
8	Taxoids (Taxanes)IBA 03/2012 - 06/2000
7	Trastuzumab (Herceptin)FDA Link 12/2017 - 10/2005
7	Docetaxel (Taxotere)FDA Link 04/2016 - 03/2000
5	Phenobarbital (Luminal)FDA Link 03/2013 - 10/2010
4	Estrogens (Estrogen)FDA Link 10/2021 - 08/2000
4	Paclitaxel (Taxol)FDA LinkGeneric 08/2015 - 07/2000
4	Biomarkers (Surrogate Marker)IBA 07/2013 - 11/2004
4	Aromatase InhibitorsIBA 10/2011 - 01/2007
4	Capecitabine (Xeloda)FDA Link 09/2009 - 12/2004
4	SteroidsIBA 07/2005 - 06/2000
3	Triptorelin Pamoate (Trelstar)FDA Link 09/2017 - 09/2006
3	Gonadotropin-Releasing Hormone (GnRH)FDA Link 09/2017 - 09/2007
3	Diphosphonates (Bisphosphonates)IBA 01/2008 - 12/2000
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2006 - 01/2002
2	ErbB Receptors (EGF Receptor)IBA 01/2023 - 04/2015
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 10/2022 - 02/2012
2	N,N'-bis(4-azidobenzoyl)cystineIBA 10/2014 - 10/2014
2	taxaneIBA 03/2012 - 01/2008
2	Goserelin (Zoladex)FDA Link 10/2011 - 02/2010
2	VaccinesIBA 01/2011 - 05/2006
2	AntigensIBA 01/2011 - 05/2006
2	Proteins (Proteins, Gene)FDA Link 04/2008 - 11/2001
2	Indicators and Reagents (Reagents)IBA 04/2007 - 01/2001
2	DNA (Deoxyribonucleic Acid)IBA 07/2001 - 06/2000
2	Drug CombinationsIBA 03/2001 - 03/2000
2	Gemcitabine FDA Link 02/2001 - 07/2000
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 10/2022
1	Cytotoxins (Cytolysins)IBA 03/2012
1	eribulin FDA Link 03/2012
1	130-nm albumin-bound paclitaxelIBA 03/2012
1	ixabepilone (BMS 247550)FDA Link 03/2012
1	Platinum Compounds (Compounds, Platinum)IBA 02/2012
1	Alkylating AgentsIBA 02/2012
1	1-dodecylpyridoxal (PLD)IBA 02/2010
1	liposomal doxorubicin (Doxil)FDA Link 02/2010
1	Etoposide (VP 16)FDA LinkGeneric 12/2009
1	Bleomycin (Blenoxane)FDA LinkGeneric 12/2009
1	SaltsIBA 05/2009
1	Valproic Acid (Depakote)FDA LinkGeneric 01/2009
1	Histone Deacetylase InhibitorsIBA 01/2009
1	Bevacizumab (Avastin)FDA Link 11/2008
1	Angiogenesis InhibitorsIBA 11/2008
1	exemestane (Aromasin)FDA Link 07/2008

Therapy/Procedure

55	Drug Therapy (Chemotherapy) 09/2017 - 01/2000
51	Therapeutics 10/2022 - 11/2000
11	Adjuvant Chemotherapy 09/2017 - 02/2000
9	Radiotherapy 12/2017 - 08/2000
6	Combination Drug Therapy (Combination Chemotherapy) 02/2012 - 01/2001
4	ViFuP protocol 10/2003 - 01/2000
3	Mastectomy (Mammectomy) 11/2012 - 04/2003
2	Mammaplasty (Breast Reconstruction) 01/2020 - 03/2013
2	Segmental Mastectomy (Lumpectomy) 12/2017 - 10/2003
2	Neoadjuvant Therapy 04/2016 - 02/2015
2	Catheters 05/2009 - 04/2004
2	Central Venous Catheters 04/2004 - 01/2001
1	Gastrectomy 04/2016
1	Aftercare (After-Treatment) 05/2012
1	Metronomic Administration 02/2010
1	Orchiectomy (Orchidectomy) 12/2009
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 09/2009